In Our Control (63 page)

128.
Agosti and Goldie, “Introducing HPV Vaccine in Developing Countries,” 1908.

129.
Rosenthal, “Drug Makers’ Push,” A1.

130.
Karl Stark, “Cancer Vaccine Donation,”
Philadelphia Inquirer
, September 27, 2007, C02.

131.
Agosti and Goldie, “Introducing HPV Vaccine in Developing Countries,” 1909.

132.
Eric J. Suba and Stephen S. Raab, letter to the editor,
New England Journal of Medicine
357, no. 11 (September 13, 2007): 1155.

133.
Anna Koulova et al., “Country Recommendations on the Inclusion of HPV Vaccines in National Immunization Programmes among High-Income Countries, June 2006-January 2008,”
Vaccine
26, no. 51 (December 2, 2008): 6530.

134.
Ibid.

Chapter Ten: What About the Boys

    
1.
Barbara Seaman and Gideon Seaman,
Women and the Crisis in Sex Hormones
(New York: Bantam, 1978), 325.

    
2.
Ibid., 301.

    
3.
Interview in
The Pill
, directed by Erna Buffle and Elsie Swerhone (Montreal: National Film Board of Canada, 1999).

    
4.
Elizabeth Siegel Watkins,
On the Pill: A Social History of Oral Contraceptives, 1950–1970
(Baltimore and London: Johns Hopkins University Press, 1998), 20.

    
5.
Gregory Pincus,
The Control of Fertility
(New York: Academic Press, 1965), 194.

    
6.
Nelly Oudshoorn,
The Male Pill
(Durham, NC, and London: Duke University Press, 2003), 23.

    
7.
Lara V. Marks, “Human Guinea Pigs? The History of Early Oral Contraceptive Clinical Trials,”
History and Technology
15, no. 4 (1999): 270–71.

    
8.
Oudshoorn,
Male Pill
, 31.

    
9.
Ibid., 32.

  
10.
Zahra Meghani, “Of Sex, Nationalities and Populations: The Construction of Menstruation as a Patho-Physiology,” in
Menstruation: A Cultural History
, ed. Andrew Shail and Gillian Howie (New York: Palgrave Macmillan, 2005), 130–45.

  
11.
The Pill
, directed by Erna Buffie and Elsie Swerhone (Montreal: National Film Board of Canada, 1999).

  
12.
Y. Wong, Y. Lous, and X. Tang, “Studies on the Antifertility Actions of Cottonseed Meal and Gossypol,”
Acta Pharmacologica Sinica
14 (1979):
662–66
.

  
13.
Elsimar Metzker Coutinho, “Gossypol: A Contraceptive for Men,”
Contraception
65, no. 4 (April 2002): 259.

  
14.
G. Z. Liu, C. K. Lyle, and J. Cao, “Trial of Gossypol as a Male Contraceptive,” in
Gossypol: A Potential Contraceptive for Men
, ed. S. J. Segal (New York: Plenum Press, 1985), 9–16.

  
15.
Coutinho, “Gossypol,” 259.

  
16.
Michelle Goldberg,
The Means of Reproductions: Sex, Power and the Future of the World
(New York: Penguin Press, 2009),
6
.

  
17.
Steven W. Sinding, “What Has Happened to Family Planning Since Cairo and What Are the Prospects for the Future?”
Contraception
78, no. 4 (October 2008): S3-S6.

  
18.
Meika Loe,
The Rise of Viagra: How the Little Blue Pill Changed Sex in America
(New York and London: New York University Press, 2004).

  
19.
Dorothy Bonn, “Male Contraceptive Research Steps Back into Spotlight,”
Lancet 353
, no. 9149 (January 23, 1998): 302.

  
20.
Michael J. K. Harper, “Public-Private Partnerships Advance Contraceptive Research and Development,”
Contraception
78, no. 4 (October 2008): S36-S41.

  
21.
C. W. Martin et al., “Potential Impact of Hormonal Male Contraception: Cross-Cultural Implications for Development of Novel Preparations,”
Human Reproduction
15, no. 3 (March 2000): 637–45.

  
22.
A. F. Glasier et al., “Would Women Trust Their Partners to Use a Male Pill?”
Human Reproduction
15, no. 3 (March 2000): 646–49.

  
23.
In Their Own Right: Addressing the Sexual and Reproductive Health Needs of Men Worldwide
(New York: Alan Guttmacher Institute, 2003), 29–30.

  
24.
Oudshoorn,
Male Pill
, 122.

  
25.
Klaas Heinemann et al., “Attitudes Toward Male Fertility Control: Results of a Multi-national Survey on Four Continents,”
Human Reproduction
20, no. 2 (2005): 549–56.

  
26.
Jacqueline E. Darroch, “Male Fertility Control—Where Are the Men?”
Contraception
78, no. 4 (October 2008): S12.

  
27.
Ibid., S7-S17.

  
28.
Jacqueline E. Darroch, “Family Planning: A Century of Change,” in
Silent Victories: The History and Practice of Public Health in Twentieth Century America
, ed. J. W. Ward and C. Warren (New York: Oxford University Press, 2006), 253–78.

  
29.
Karin Ringheim, “Reversing the Downward Trend in Men’s Share of Contraceptive Use,”
Reproductive Health Matters
7, no. 14 (November 1999): 83–96.

  
30.
Darroch, “Male Fertility Control,” S7-S17.

  
31.
Barbara Seaman and Laura Eldridge,
The No-Nonsense Guide to Menopause
(New York: Simon and Schuster, 2008), 388.

  
32.
Oudshoorn,
Male Pill
, 108.

  
33.
John K. Amory, “Progress and Prospects in Male Hormonal Contraception,”
Current Opinion in Endocrinology, Diabetes and Obesity
15, no. 3 (June 2008): 255–60.

  
34.
World Health Organization Task Force on Methods for the Regulation of Male Fertility, “Contraceptive Efficacy of Testosterone-Induced Azoospermia in Normal Men,”
Lancet
336, no. 8721 (October 20, 1990): 955–59.

  
35.
World Health Organization Task Force on Methods for the Regulation of Male Fertility, “Contraceptive Efficacy of Testosterone-Induced Azoospermia and Oligozoospermia in Normal Men,”
Fertility and Sterility
65, no. 4 (April 1996): 821–29.

  
36.
D. M. Brady et al., “A Multicentre Study Investigating Subcutaneous Etonogestrel Implants with Injectable Testosterone Decanoate as a Potential Long-Acting Male Contraceptive,”
Human Reproduction
21, no. 1 (January 2006): 285–94.

  
37.
Yi-Qun Gu et al., “A Multicenter Contraceptive Efficacy Study of Injectable Testosterone Undecanoate in Healthy Chinese Men,”
Journal of Clinical Endocrinology & Metabolism
88, no. 2 (February 2003): 562–68.

  
38.
Axel Kamischke et al., “Intramuscular Testosterone Undecanoate and Norethisterone Enanthate in a Clinical Trial for Male Contraception,”
Journal of Clinical Endocrinology & Metabolism
86, no. 1 (January 2001): 303–9.

  
39.
John K. Amory et al., “Acceptability of a Combination Testosterone Gel and Depomedroxyprogesterone Acetate Male Contraceptive Regimen,”
Contraception
75, no. 3 (March 2007): 218–23.

  
40.
David A. Grimes et al., “Steroid Hormones for Contraception in Men: Systematic Review of Randomized Controlled Trials,”
Contraception
71, no. 2 (February 2005): 89–94.

  
41.
Diana Blithe, “Male Contraception: What Is on the Horizon?”
Contraception
78, no. 4 (October 2008): S23-S27.

  
42.
Stephanie T. Page, John K. Amory, and William J. Bremner, “Advances in Male Contraception,”
Endocrine Reviews
29, no. 4 (2008): 465–93.

  
43.
Regine Sitruk-Ware, “Contraception: An International Perspective,”
Contraception
73, no. 3 (March 2006): 220.

  
44.
Coutinho, “Gossypol,” 260.

  
45.
Guang-Hui Cui et al., “A Combined Regimen of Gossypol Plus Methyltestosterone and Ethinylestradiol as a Contraceptive Induces Germ Cell Apoptosis and Expression of its Related Genes in Rats,”
Contraception
70, no. 4 (October 2004): 335–42; Zhan-Jun Yang et al., “Combined Administration of Low-Dose Gossypol Acetic Acid with Desogestrel/Mini-Dose Enthinylestradiol/Testosterone Undecanoate as an Oral Contraceptive for Men,”
Contraception
70, no. 3 (September 2004): 203–11.

  
46.
Bonn, “Male Contraceptive Research,” 302.

  
47.
Page, Amory, and Bremner, “Advances in Male Contraception,” 481.

  
48.
Dejian Ren et al., “A Sperm Ion Channel Required for Sperm Motility and Male Fertility,”
Nature
413, no. 6856 (October 11, 2001): 603–9.

  
49.
Kathryn Senior, “Non-Hormonal Male Contraceptive on the Horizon?”
Lancet
358, no. 9289 (October 13, 2001): 1244.

  
50.
Joan Stephenson, “A Hormone-Free Male ‘Pill’?”
Journal of the American Medical Association
289, no. 2 (January 8, 2003): 164.

  
51.
J. K. Amory et al., “Miglustat Has No Apparent Effect on Spermatogenesis in Normal Men,”
Human Reproduction
22, no. 3 (March 2007): 702–7.

  
52.
Eberhard Nieschlag and Alexander Henke, “Hopes for Male Contraception,”
Lancet
365, no. 9459 (February 12, 2005): 554–56.

  
53.
Page, Amory, and Bremner, “Advances in Male Contraception,” 482–83.